The Health Consequences of Discontinuing CPAP Therapy

For individuals diagnosed with obstructive sleep apnea (OSA), adhering to prescribed Continuous Positive Airway Pressure (CPAP) therapy is a key part of managing the condition. Discontinuing or inconsistently using a CPAP device can lead to a rapid resurgence of symptoms and expose an individual to significant health risks [1, 2]. 

Clinical studies demonstrate that even a short-term withdrawal from CPAP therapy can result in a significant increase in apnea events, drops in blood oxygen levels, and spikes in blood pressure during sleep [1]. Consistent therapy is the cornerstone of effective OSA management. Modern portable devices, such as the Transcend Micro™, are designed to facilitate therapy adherence by making it easier to continue treatment without interruption, whether at home or while traveling. 

Immediate Consequences of Pausing CPAP Therapy (First 1-3 Nights) 

Skipping even a single night of CPAP therapy typically results in the immediate return of OSA symptoms [1]. The protective pressure that keeps the airway open is gone, leading to a cascade of physiological effects: 

• Resumption of Breathing Interruptions: The airway collapses repeatedly, causing apneas (pauses in breathing) and hypopneas (shallow breathing). For individuals with severe OSA, this can mean more than 30 breathing interruptions per hour [2]. 

• Drop in Blood Oxygen Levels: Each apnea event can cause a significant drop in blood oxygen saturation (SpO2). These intermittent hypoxic events place considerable stress on the body, particularly the cardiovascular system [1]. 

• Deterioration of Sleep Quality: The brain must arouse itself from sleep to signal the body to resume breathing. These micro-awakenings fragment the sleep architecture, preventing the deep, restorative stages of sleep necessary for physical and cognitive recovery [2]. 

• Return of Loud Snoring: Without the pneumatic splint of the CPAP, the soft tissues of the airway vibrate, causing loud snoring to return. This not only impacts the user’s sleep but can also severely disrupt the sleep of a bed partner [1]. 

The Impact on Daytime Functioning and Safety 

After just one night without CPAP therapy, the effects of fragmented sleep and oxygen deprivation become apparent during waking hours [3]. Excessive daytime sleepiness is one of the most common and debilitating consequences. 

This fatigue significantly impairs cognitive functions such as attention, vigilance, and executive function [3]. For untreated OSA patients, this creates a dangerous risk for accidents, particularly while driving. Multiple studies have confirmed that individuals with untreated OSA have a significantly higher risk of motor vehicle crashes compared to the general population. However, consistent use of CPAP therapy has been shown to reduce this risk by up to 70% [4]. 

Cardiovascular and Systemic Health Risks 

Discontinuing CPAP therapy places immediate and cumulative stress on the cardiovascular system [1]. Each apnea event triggers a “fight-or-flight” response, flooding the body with stress hormones like adrenaline and cortisol [5]. This leads to several dangerous complications: 

• Blood Pressure Surges: During apnea events, blood pressure can spike significantly. This nocturnal hypertension contributes to the development of sustained high blood pressure over time [1]. 

• Increased Risk of Heart Rhythm Disorders: OSA is strongly linked to an increased prevalence of atrial fibrillation (AFib), the most common type of heart arrhythmia. The stress and oxygen deprivation caused by apneas can trigger and perpetuate AFib [5]. 

• Elevated Risk of Sudden Cardiac Death: While the absolute risk varies, studies have shown that individuals with severe, untreated OSA have a higher risk of sudden cardiac death, particularly during the sleeping hours between midnight and 6 a.m., compared to the general population [6]. 

Long-Term Health Consequences of Untreated OSA 

When CPAP therapy is stopped for an extended period, a patient is no longer protected from the cumulative effect of nightly apneas, hypoxia, and stress hormone release, which can lead to the development of serious, life-altering chronic diseases [7, 11]. 

Health Condition	Association with Untreated OSA
Cardiovascular Disease	Untreated OSA is an independent risk factor for hypertension, coronary artery disease, heart attack, and stroke [7].
Type 2 Diabetes	OSA is linked to impaired glucose metabolism and insulin resistance, increasing the risk of developing tType 2 diabetes [8].
Cognitive Decline	Chronic intermittent hypoxia can negatively impact brain structures involved in memory and executive function, potentially accelerating cognitive decline [9].
Non-alcoholic Fatty Liver Disease	The repeated drops in oxygen associated with OSA can contribute to liver inflammation and damage [7].

Ensuring Therapy Continuity in All Scenarios 

Life is unpredictable, but interruptions to CPAP therapy can be avoided with the right planning and equipment. Portable devices are designed to address common challenges to therapy adherence [10]. 

• Travel: Traditional CPAP machines can be bulky. A portable device like the Transcend Micro, which is FAA-compliant and weighs 0.48 lbs (219.5g), allows for seamless therapy continuation during travel [10]. 

• Power Outages: A power outage can interrupt therapy at home. Using a dedicated battery backup, such as the Transcend PowerAway™ battery, ensures your device continues to function through the night [10]. 

• Outdoor Activities: For camping or other off-grid activities, a combination of a portable CPAP and a battery solution makes it possible to maintain therapy without access to mains power [10]. 

Important Safety Information 

Before starting any PAP therapy, it is crucial to discuss your full medical history with your physician. The Transcend Micro may be contraindicated in patients with certain conditions, including bullous lung disease, pathologically low blood pressure, pneumothorax, or a history of cerebral spinal fluid (CSF) leaks. For a complete list of contraindications, warnings, and potential adverse effects, please refer to the official Transcend Micro User Manual [10]. 

Frequently Asked Questions 

Can you die from not using your CPAP machine? 

While it is rare for a person to die from a single night without CPAP, severe, untreated obstructive sleep apnea is associated with an increased risk of all-cause mortality over the long term, including a higher risk of sudden cardiac death [6, 11]. The risk is most significant for individuals with severe OSA and pre-existing cardiovascular conditions. 

What happens if you don’t use your CPAP for one night? 

One night without CPAP therapy will typically cause a full return of your sleep apnea symptoms, including snoring and breathing interruptions. This leads to poor sleep quality, daytime fatigue, and measurable stress on your cardiovascular system, such as temporary spikes in blood pressure during sleep [1]. 

How long can you go without using your CPAP? 

For therapy to be effective, it should be used every night. There is no “safe” period to go without your device. Any interruption in therapy leads to a return of symptoms and health risks. If you anticipate being without power or traveling, it is important to plan ahead with solutions like a portable device or battery backup. 

Disclaimer 

The information provided in this article is for general informational and marketing purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please consult with your physician or another qualified healthcare provider if you have any questions about a medical condition or the use of a CPAP device. The Transcend Micro CPAP is a medical device that requires a prescription and should be used only as directed by a physician. For detailed information on indications for use, contraindications, warnings, and precautions, please refer to the official Transcend Micro User Manual [10]. 

References 

1. Kohler, M., et al. (2008). The effect of CPAP withdrawal on blood pressure in obstructive sleep apnoea. Thorax, 63(12), 1124–125. https://thorax.bmj.com/content/63/12/1124.2.long 

2. American Academy of Sleep Medicine. (2014). International Classification of Sleep Disorders – Third Edition (ICSD-3). 

3. Lal, C., et al. (2021). Neurocognitive impairment in obstructive sleep apnea. Sleep Medicine Clinics, 16(3), 477–486. 

4. George, C. F. (2007). Sleep apnea, alertness, and motor vehicle crashes. American Journal of Respiratory and Critical Care Medicine, 176(10), 954–956. https://www.atsjournals.org/doi/full/10.1164/rccm.200707-1044ED 

5. Mehra, R., et al. (2006). Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. American Journal of Respiratory and Critical Care Medicine, 173(8), 910–916. https://www.atsjournals.org/doi/full/10.1164/rccm.200509-1442OC 

6. Gami, A. S., et al. (2005). Day–night pattern of sudden death in obstructive sleep apnea. The New England Journal of Medicine, 352(12), 1206–1214. https://www.nejm.org/doi/full/10.1056/NEJMoa041832 

7. Yeghiazarians, Y., et al. (2021). Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation, 144(3), e56–e67. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000988 

8. Reutrakul, S., & Mokhlesi, B. (2017). Obstructive sleep apnea and diabetes: a state-of-the-art review. Chest, 152(5), 1070–1086. https://pmc.ncbi.nlm.nih.gov/articles/PMC5812754/ 

9. An, J., et al. (2022). The effect of obstructive sleep apnea on cognitive function: A systematic review and meta-analysis. Journal of Clinical Neurology, 18(1), 1–11. 

10. Transcend Inc. (2025). Transcend Micro User Manual (104149 Rev F). Available at: https://mytranscend.com/wp-content/uploads/2025/12/104149-Rev-F.pdf
     
11. Young, T., et al. (2008). Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. Sleep, 31(8), 1071–1078. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2542952/